Faeth Therapeutics FTH
NASDAQ FTH
$39.00 +2.88 (+7.97%)
As of: Sep 10, 2026 · 3:59 PM EDT

Faeth Therapeutics (FTH) Prepaid Assets (2020 - 2026)

Faeth Therapeutics' (FTH) quarterly Prepaid Assets came in at $1.4 million in Q2 2026, up 64.13% on a YoY basis from $828000.0 in Q2 2025, and up 39.53% quarter-over-quarter from $974000.0 in Q1 2026.

Analysis

Faeth Therapeutics (FTH) Prepaid Assets (2020 - 2026) Analysis & Trends

Faeth Therapeutics (FTH) has reported Prepaid Assets for 7 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets rose 64.13% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $1.4 million (up 64.13% YoY), and the FY2025 full-year result was $231000.0, down 51.27% from the prior year.
  • Prepaid Assets rose to $1.4 million in Q2 2026 per FTH's latest filing, from $974000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.5 million in Q2 2022 and bottomed at $231000.0 in Q4 2025.
  • Historically, Prepaid Assets has averaged $1.4 million across 5 years, with a median of $1.3 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 106.4% in 2022, then slumped 59.42% in 2024.
  • Over 5 years, Prepaid Assets stood at $1.1 million in 2022, then increased by 3.45% to $1.2 million in 2023, then plunged by 59.42% to $474000.0 in 2024, then tumbled by 51.27% to $231000.0 in 2025, then surged by 488.31% to $1.4 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.4 million, $974000.0, and $231000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Faeth Therapeutics 218.99 Mn 218.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.36 Mn
Mar 31, 2026 974,000.00
Dec 31, 2025 231,000.00
Sep 30, 2025 496,000.00
Jun 30, 2025 828,000.00
Mar 31, 2025 911,000.00
Dec 31, 2024 474,000.00
Sep 30, 2024 1.02 Mn
Jun 30, 2024 1.51 Mn
Mar 31, 2024 1.88 Mn
Dec 31, 2023 1.17 Mn
Sep 30, 2023 1.51 Mn
Jun 30, 2023 1.98 Mn
Mar 31, 2023 2.65 Mn
Dec 31, 2022 1.13 Mn
Sep 30, 2022 1.59 Mn
Jun 30, 2022 3.48 Mn
Mar 31, 2022 2.55 Mn
Dec 31, 2021 547,000.00
Sep 30, 2021 1.20 Mn